After finishing at $27.22 in the prior trading day, Prothena Corporation plc (NASDAQ: PRTA) closed at $28.18, up 3.53%. In other words, the price has increased by $+0.96 from its previous closing price. On the day, 537535 shares were traded.
Ratios:
Our goal is to gain a better understanding of PRTA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.24 and its Current Ratio is at 11.24. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2024, Downgraded its rating to Neutral and sets its target price to $38 from $68 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $62.
On April 24, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $80.SVB Securities initiated its Outperform rating on April 24, 2023, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 24 when Walker Karin L sold 5,000 shares for $34.00 per share. The transaction valued at 170,000 led to the insider holds 0 shares of the business.
Walker Karin L sold 5,000 shares of PRTA for $185,952 on Dec 20. The Chief Accounting Officer now owns 0 shares after completing the transaction at $37.19 per share. On Nov 30, another insider, Walker Karin L, who serves as the Chief Accounting Officer of the company, sold 5,000 shares for $34.00 each. As a result, the insider received 170,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRTA now has a Market Capitalization of 1.51B and an Enterprise Value of 906.85M. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.57 while its Price-to-Book (P/B) ratio in mrq is 2.69. Its current Enterprise Value per Revenue stands at 9.93 whereas that against EBITDA is -4.77.
Stock Price History:
The Beta on a monthly basis for PRTA is 0.22, which has changed by -51.18% over the last 52 weeks, in comparison to a change of 28.18% over the same period for the S&P500. Over the past 52 weeks, PRTA has reached a high of $79.65, while it has fallen to a 52-week low of $24.28. The 50-Day Moving Average of the stock is 33.07, while the 200-Day Moving Average is calculated to be 49.75.
Shares Statistics:
The stock has traded on average 886.17K shares per day over the past 3-months and 796.78k shares per day over the last 10 days, according to various share statistics. A total of 53.68M shares are outstanding, with a floating share count of 46.38M. Insiders hold about 13.66% of the company’s shares, while institutions hold 98.80% stake in the company. Shares short for PRTA as of Jan 31, 2024 were 5.75M with a Short Ratio of 6.49, compared to 6.08M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 10.71% and a Short% of Float of 15.62%.
Earnings Estimates
Its stock is currently analyzed by 7 different market analysts. On average, analysts expect EPS of -$1.21 for the current quarter, with a high estimate of -$1.11 and a low estimate of -$1.42, while EPS last year was -$0.89. The consensus estimate for the next quarter is -$1.22, with high estimates of -$1.12 and low estimates of -$1.44.
Analysts are recommending an EPS of between -$4.48 and -$5.82 for the fiscal current year, implying an average EPS of -$4.98. EPS for the following year is -$4.13, with 9 analysts recommending between -$0.49 and -$6.51.
